industry news

摘要

UK AstraZeneca has announced a major shake-up to its business. In a move to focus on main therapy areas, the British biopharma giant has created two R&D units to work on discovery through to late-stage development: one for BioPharmaceutical therapies, and one for Oncology. These R&D units are mirrored with commercial units in both.